# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 46: Amendment to regulation 58F

Extent: E+W+S+N.I.

In regulation 58F(1)(b) (consideration of applications relating to conditional marketing authorisations), for “UKMA(GB)” substitute “UKMA(UK)(Category 1)”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/46 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-46
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

